{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:43:13Z","timestamp":1793371393769,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2025-151"],"award-info":[{"award-number":["BJ-2025-151"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2025-122"],"award-info":[{"award-number":["BJ-2025-122"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373272"],"award-info":[{"award-number":["82373272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["52273281"],"award-info":[{"award-number":["52273281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02642-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:42:26Z","timestamp":1773718946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["GPR183 potentiates CAR-T cell infiltration and antitumor immunity through a positive feedback loop involving the oxysterol 7\u03b1,25-OHC"],"prefix":"10.1186","volume":"25","author":[{"given":"Rui","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlian","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"2642_CR1","doi-asserted-by":"publisher","first-page":"102129","DOI":"10.1016\/j.nantod.2023.102129","volume":"54","author":"Y Lu","year":"2024","unstructured":"Lu Y, Liu X, You J. Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity. Nano Today. 2024;54:102129.","journal-title":"Nano Today"},{"key":"2642_CR2","doi-asserted-by":"crossref","unstructured":"Huang H, Yu L, Weng H, Zhang W, Wang Z, Wang L, Huang H. Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress. J Hematol Oncol. 2024;17:120.","DOI":"10.1186\/s13045-024-01639-1"},{"key":"2642_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365:725\u201333.","journal-title":"N Engl J Med"},{"key":"2642_CR4","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1016\/j.apsb.2024.04.022","volume":"14","author":"D Xiong","year":"2024","unstructured":"Xiong D, Yu H, Sun Z-J. Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy. Acta Pharm Sinica B. 2024;14:3416\u201331.","journal-title":"Acta Pharm Sinica B"},{"key":"2642_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12935-024-03315-3","volume":"24","author":"T Chen","year":"2024","unstructured":"Chen T, Wang M, Chen Y, Liu Y. Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors. Cancer Cell Int. 2024;24:133.","journal-title":"Cancer Cell Int"},{"key":"2642_CR6","doi-asserted-by":"crossref","unstructured":"Kwon N, Chen YY. Overcoming solid-tumor barriers: armored CAR-T cell therapy. Trends Cancer. 2025;11:1019-29.","DOI":"10.1016\/j.trecan.2025.08.009"},{"key":"2642_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-021-01168-1","volume":"14","author":"F Ji","year":"2021","unstructured":"Ji F, Zhang F, Zhang M, Long K, Xia M, Lu F, Li E, Chen J, Li J, Chen Z, et al. Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway. J Hematol Oncol. 2021;14:152.","journal-title":"J Hematol Oncol"},{"key":"2642_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14:91.","journal-title":"J Hematol Oncol"},{"key":"2642_CR9","doi-asserted-by":"publisher","first-page":"106701","DOI":"10.1016\/j.phrs.2023.106701","volume":"189","author":"L Fang","year":"2023","unstructured":"Fang L, Tian W, Zhang C, Wang X, Li W, Zhang Q, Zhang Y, Zheng J. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma. Pharmacol Res. 2023;189:106701.","journal-title":"Pharmacol Res"},{"key":"2642_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1158\/2326-6066.CIR-16-0348","volume":"5","author":"E Lo Presti","year":"2017","unstructured":"Lo Presti E, Toia F, Oieni S, Buccheri S, Turdo A, Mangiapane LR, Campisi G, Caputo V, Todaro M, Stassi G, et al. Squamous Cell Tumors Recruit \u03b3\u03b4 T Cells Producing either IL17 or IFN\u03b3 Depending on the Tumor Stage. Cancer Immunol Res. 2017;5:397\u2013407.","journal-title":"Cancer Immunol Res"},{"key":"2642_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mattod.2023.03.006","volume":"65","author":"A Erfani","year":"2023","unstructured":"Erfani A, Diaz AE, Doyle PS. Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment. Mater Today. 2023;65:227\u201343.","journal-title":"Mater Today"},{"key":"2642_CR12","doi-asserted-by":"crossref","unstructured":"Epperly R, Gottschalk S, DeRenzo C. CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives. EJC Paediatr Oncol. 2024;:100160.","DOI":"10.1016\/j.ejcped.2024.100160"},{"key":"2642_CR13","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/eji.201444493","volume":"44","author":"V Daugvilaite","year":"2014","unstructured":"Daugvilaite V, Arfelt KN, Benned-Jensen T, Sailer AW, Rosenkilde MM. Oxysterol-EBI2 signaling in immune regulation and viral infection. Eur J Immunol. 2014;44:1904\u201312.","journal-title":"Eur J Immunol"},{"key":"2642_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2015.00060","volume":"6","author":"S Sun","year":"2015","unstructured":"Sun S, Liu C. 7\u03b1, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseases. Front Pharmacol. 2015;6:60.","journal-title":"Front Pharmacol"},{"key":"2642_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10280","volume":"475","author":"S Hannedouche","year":"2011","unstructured":"Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, Pereira JP, Guerini D, Baumgarten BU, Roggo S, Wen B, et al. Oxysterols direct immune cell migration via EBI2. Nature. 2011;475:524\u20137.","journal-title":"Nature"},{"key":"2642_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.it.2013.01.007","volume":"34","author":"D Gatto","year":"2013","unstructured":"Gatto D, Brink R. B cell localization: regulation by EBI2 and its oxysterol ligand. Trends Immunol. 2013;34:336\u201341.","journal-title":"Trends Immunol"},{"key":"2642_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2017.11.020","volume":"48","author":"J Emg\u00e5rd","year":"2018","unstructured":"Emg\u00e5rd J, Kammoun H, Garc\u00eda-Cassani B, Chesn\u00e9 J, Parigi SM, Jacob JM, Cheng HW, Evren E, Das S, Czarnewski P, et al. Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation. Immunity. 2018;48:120\u2013e132128.","journal-title":"Immunity"},{"key":"2642_CR18","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/bph.13801","volume":"174","author":"V Daugvilaite","year":"2017","unstructured":"Daugvilaite V, Madsen CM, L\u00fcckmann M, Echeverria CC, Sailer AW, Frimurer TM, Rosenkilde MM, Benned-Jensen T. Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2. Br J Pharmacol. 2017;174:2031\u201342.","journal-title":"Br J Pharmacol"},{"key":"2642_CR19","doi-asserted-by":"publisher","unstructured":"Yang Y, Li L, Shen L, Wang Y, Zhang H, Wang T, Cao W. A Pan-cancer analysis of GPR183 correlated with tumor immunity. Res Square. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-42118\/v1.","DOI":"10.21203\/rs.3.rs-42118\/v1"},{"key":"2642_CR20","doi-asserted-by":"publisher","first-page":"1130052","DOI":"10.3389\/fimmu.2023.1130052","volume":"14","author":"ML Ribeiro","year":"2023","unstructured":"Ribeiro ML, Profit\u00f3s-Pelej\u00e0 N, Santos JC, Blecua P, Reyes-Garau D, Armengol M, Fern\u00e1ndez-Serrano M, Miskin HP, Bosch F, Esteller M, et al. G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20\/PI3K\u03b4i dual therapy. Front Immunol. 2023;14:1130052.","journal-title":"Front Immunol"},{"key":"2642_CR21","doi-asserted-by":"crossref","unstructured":"Song H, Tang X, Liu M, Wang G, Yuan Y, Pang R, Wang C, Zhou J, Yang Y, Zhang M et al. Multi-omic analysis identifies metabolic biomarkers for the early detection of breast cancer and therapeutic response prediction. iScience. 2024;27:110682.","DOI":"10.1016\/j.isci.2024.110682"},{"key":"2642_CR22","doi-asserted-by":"crossref","unstructured":"Rannikko JH, Turpin R, Bostr\u00f6m P, Virtakoivu R, Harth C, Takeda A, Tamminen A, Koskivuo I, Hollm\u00e9n M. Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment. J Immunother Cancer. 2025;13:e011292.","DOI":"10.1136\/jitc-2024-011292"},{"key":"2642_CR23","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-025-57603-1","volume":"16","author":"Z Wen","year":"2025","unstructured":"Wen Z, Liu T, Xu X, Acharya N, Shen Z, Lu Y, Xu J, Guo K, Shen S, Zhao Y, et al. Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice. Nat Commun. 2025;16:2362.","journal-title":"Nat Commun"},{"key":"2642_CR24","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chen H, Mo H, Hu X, Gao R, Zhao Y, Liu B, Niu L, Sun X, Yu X, et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell. 2021;39:1578\u2013e15931578.","journal-title":"Cancer Cell"},{"key":"2642_CR25","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, Thennavan A, Wang C, Torpy JR, Bartonicek N, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347.","journal-title":"Nat Genet"},{"key":"2642_CR26","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","volume":"28","author":"J Xu","year":"2022","unstructured":"Xu J, Fang Y, Chen K, Li S, Tang S, Ren Y, Cen Y, Fei W, Zhang B, Shen Y, Lu W. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer. Clin Cancer Res. 2022;28:3590\u2013602.","journal-title":"Clin Cancer Res"},{"key":"2642_CR27","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"2642_CR28","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"2642_CR29","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3389\/fimmu.2017.01564","volume":"8","author":"D Presotto","year":"2017","unstructured":"Presotto D, Erdes E, Duong MN, Allard M, Regamey PO, Quadroni M, Doucey MA, Rufer N, Hebeisen M. Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms. Front Immunol. 2017;8:1564.","journal-title":"Front Immunol"},{"key":"2642_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1158\/2159-8290.CD-22-1125","volume":"13","author":"Y Ito","year":"2023","unstructured":"Ito Y, Pan D, Zhang W, Zhang X, Juan TY, Pyrdol JW, Kyrysyuk O, Doench JG, Liu XS, Wucherpfennig KW. Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines. Cancer Discov. 2023;13:1186\u2013209.","journal-title":"Cancer Discov"},{"key":"2642_CR31","doi-asserted-by":"crossref","unstructured":"Cui K, He W, Huang N, Zhu S, Jiang D, Yang W, Zeng Y, Farooq MA, Xu G. The challenges and progress of CAR-T cell therapy in the treatment of solid tumors. Mol Cell Biochem. 2025;480:5345-67.","DOI":"10.1007\/s11010-025-05329-5"},{"key":"2642_CR32","doi-asserted-by":"publisher","first-page":"687822","DOI":"10.3389\/fimmu.2021.687822","volume":"12","author":"L Miao","year":"2021","unstructured":"Miao L, Zhang Z, Ren Z, Tang F, Li Y. Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors. Front Immunol. 2021;12:687822.","journal-title":"Front Immunol"},{"key":"2642_CR33","doi-asserted-by":"crossref","unstructured":"Caza T, Landas S. Functional and Phenotypic Plasticity of CD4(+) T Cell Subsets. Biomed Res Int. 2015;2015:521957.","DOI":"10.1155\/2015\/521957"},{"key":"2642_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41577-024-01025-5","volume":"24","author":"I Comerford","year":"2024","unstructured":"Comerford I, McColl SR. Atypical chemokine receptors in the immune system. Nat Rev Immunol. 2024;24:753\u201369.","journal-title":"Nat Rev Immunol"},{"key":"2642_CR35","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhao L, Liu J, Yang X, Chen T, Chen Z, Li W, Hu Z, Pan F, Chen J et al. CCR2\/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells. Cell Mol Life Sci. 2025;83:9.","DOI":"10.1007\/s00018-025-05972-7"},{"key":"2642_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"key":"2642_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.22578\/IJMS.16.2.12","volume":"16","author":"Z Mohammed","year":"2018","unstructured":"Mohammed Z, Al-Saeed H, Undefined U, Nile A. Undefined U: The level of 27-Hydroxycholesterol And Oxysterol 7 \u03b1-Hydroxylase (CYP7B1) in Tissues of women with breast tumors. Iraqi J Med Sci. 2018;16:201\u20136.","journal-title":"Iraqi J Med Sci"},{"key":"2642_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/pros.20630","volume":"67","author":"M Olsson","year":"2007","unstructured":"Olsson M, Gustafsson O, Skogastierna C, Tolf A, Rietz BD, Morfin R, Rane A, Ekstr\u00f6m L. Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. Prostate. 2007;67:1439\u201346.","journal-title":"Prostate"},{"key":"2642_CR39","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20131335","volume":"210","author":"AG York","year":"2013","unstructured":"York AG, Bensinger SJ. Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth. J Exp Med. 2013;210:1653\u20136.","journal-title":"J Exp Med"},{"key":"2642_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1158\/1541-7786.MCR-22-0602","volume":"21","author":"N McBrearty","year":"2023","unstructured":"McBrearty N, Cho C, Chen J, Zahedi F, Peck AR, Radaelli E, Assenmacher CA, Pavlak C, Devine A, Yu P, et al. Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells. Mol Cancer Res. 2023;21:228\u201339.","journal-title":"Mol Cancer Res"},{"key":"2642_CR41","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1038\/s41467-022-34428-w","volume":"13","author":"Z Lu","year":"2022","unstructured":"Lu Z, Chen J, Yu P, Atherton MJ, Gui J, Tomar VS, Middleton JD, Sullivan NT, Singhal S, George SS, et al. Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer. Nat Commun. 2022;13:6623.","journal-title":"Nat Commun"},{"key":"2642_CR42","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305\u20138.","journal-title":"Science"},{"key":"2642_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrc883","volume":"2","author":"S Cory","year":"2002","unstructured":"Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002;2:647\u201356.","journal-title":"Nat Rev Cancer"},{"key":"2642_CR44","doi-asserted-by":"publisher","first-page":"15561","DOI":"10.1074\/jbc.M412630200","volume":"280","author":"Y Sun","year":"2005","unstructured":"Sun Y, Leaman DW. Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection. J Biol Chem. 2005;280:15561\u20138.","journal-title":"J Biol Chem"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02642-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:17:33Z","timestamp":1776986253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02642-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2642"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02642-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All fresh anticoagulated whole blood samples used in this study were obtained from previously stored specimens collected from peripheral blood at the Department of Laboratory Medicine, Beijing Hospital (Ethics Review Opinion Number: 2025BJYYEC-KY009-01). All animal research was performed in accordance with the Basel Declaration and approved by the Ethics Committee of Institute of Zoology Chinese Academy of Sciences (Approval Number: IOZ-IACUC-2025-110).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}